What is Vertex Pharmaceuticals's loss contingency accrual?

Vertex Pharmaceuticals (VRTX) reported loss contingency accrual of $0.00 in Q1 2026.

What does loss contingency accrual mean?

The estimated financial reserve for potential future losses from legal or operational uncertainties.

This is a positive signal — lower values indicate better performance for this metric.

StatementBalance Sheet Statement

SectionOther

CategoryRisk

SignalLower is better

VolatilityVolatile

First reportedQ4 2024

Last reportedQ1 2026May 5, 2026

An increase suggests higher legal or operational risk, while a decrease may indicate the resolution of past contingencies.

This represents the estimated liability for potential losses from legal proceedings, environmental claims, or other unce...

Standard accounting practice; peers report this based on their specific legal and environmental exposure profiles.

Metric ID: other_loss_contingency_accrual_at_carrying_value

5 periods

	Q4 '24	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$0.00	$0.00	$0.00	$0.00	$0.00

Range$0.00 – $0.00

What is Vertex Pharmaceuticals's loss contingency accrual?: Vertex Pharmaceuticals (VRTX) reported loss contingency accrual of $0.00 in Q1 2026.
What does loss contingency accrual mean?: The estimated financial reserve for potential future losses from legal or operational uncertainties.